Insulet (PODD) Revenue (2016 - 2025)
Insulet (PODD) has disclosed Revenue for 16 consecutive years, with $783.8 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 31.18% year-over-year to $783.8 million, compared with a TTM value of $2.7 billion through Dec 2025, up 30.73%, and an annual FY2025 reading of $2.7 billion, up 30.73% over the prior year.
- Revenue was $783.8 million for Q4 2025 at Insulet, up from $706.2 million in the prior quarter.
- Across five years, Revenue topped out at $783.8 million in Q4 2025 and bottomed at $252.3 million in Q1 2021.
- Average Revenue over 5 years is $452.2 million, with a median of $437.2 million recorded in 2023.
- The sharpest move saw Revenue skyrocketed 62.84% in 2022, then dropped 4.26% in 2023.
- Year by year, Revenue stood at $327.0 million in 2021, then surged by 62.84% to $532.5 million in 2022, then decreased by 4.26% to $509.8 million in 2023, then grew by 17.2% to $597.5 million in 2024, then soared by 31.18% to $783.8 million in 2025.
- Business Quant data shows Revenue for PODD at $783.8 million in Q4 2025, $706.2 million in Q3 2025, and $649.1 million in Q2 2025.